WO2001042472A3 - DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE - Google Patents
DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE Download PDFInfo
- Publication number
- WO2001042472A3 WO2001042472A3 PCT/US2000/042295 US0042295W WO0142472A3 WO 2001042472 A3 WO2001042472 A3 WO 2001042472A3 US 0042295 W US0042295 W US 0042295W WO 0142472 A3 WO0142472 A3 WO 0142472A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptides
- prost
- ets
- novel
- polypeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6843—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001544345A JP2003533177A (en) | 1999-11-30 | 2000-11-29 | DNA encoding novel PROST-Ets polypeptide |
AU43064/01A AU4306401A (en) | 1999-11-30 | 2000-11-29 | Dna encoding a novel prost-ets polypeptide |
EP00992356A EP1234037A2 (en) | 1999-11-30 | 2000-11-29 | DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
NO20022542A NO20022542L (en) | 1999-11-30 | 2002-05-29 | DNA encoding a new Ets polypeptide |
HK03101484.8A HK1049352A1 (en) | 1999-11-30 | 2003-02-28 | Dna encoding a novel prost-ets polypeptide |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16818299P | 1999-11-30 | 1999-11-30 | |
US60/168,182 | 1999-11-30 | ||
US71815900A | 2000-11-21 | 2000-11-21 | |
US09/718,159 | 2000-11-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001042472A2 WO2001042472A2 (en) | 2001-06-14 |
WO2001042472A3 true WO2001042472A3 (en) | 2002-05-10 |
Family
ID=26863872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/042295 WO2001042472A2 (en) | 1999-11-30 | 2000-11-29 | DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1234037A2 (en) |
JP (1) | JP2003533177A (en) |
AU (1) | AU4306401A (en) |
HK (1) | HK1049352A1 (en) |
NO (1) | NO20022542L (en) |
WO (1) | WO2001042472A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7867731B2 (en) | 1998-11-04 | 2011-01-11 | Novartis Vaccines And Diagnostics, Inc. | HX2004-6 polypeptide expressed in cancerous cells |
AU5132800A (en) | 1999-05-14 | 2000-12-05 | Chiron Corporation | Expression of ets-domain proteins in cancer |
CA2443123A1 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
TWI570662B (en) * | 2016-04-27 | 2017-02-11 | 國立彰化師範大學 | Gene synthesis teaching system and method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000006589A1 (en) * | 1998-07-31 | 2000-02-10 | Human Genome Sciences, Inc. | Prostate derived ets factor |
WO2000055173A1 (en) * | 1999-03-12 | 2000-09-21 | Human Genome Sciences, Inc. | Human breast and ovarian cancer associated gene sequences and polypeptides |
WO2000070092A1 (en) * | 1999-05-14 | 2000-11-23 | Chiron Corporation | Expression of ets-domain proteins in cancer |
US6265565B1 (en) * | 1998-04-03 | 2001-07-24 | Incyte Genomics, Inc. | Prostate associated Ets protein |
-
2000
- 2000-11-29 JP JP2001544345A patent/JP2003533177A/en active Pending
- 2000-11-29 EP EP00992356A patent/EP1234037A2/en not_active Withdrawn
- 2000-11-29 AU AU43064/01A patent/AU4306401A/en not_active Abandoned
- 2000-11-29 WO PCT/US2000/042295 patent/WO2001042472A2/en not_active Application Discontinuation
-
2002
- 2002-05-29 NO NO20022542A patent/NO20022542L/en unknown
-
2003
- 2003-02-28 HK HK03101484.8A patent/HK1049352A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265565B1 (en) * | 1998-04-03 | 2001-07-24 | Incyte Genomics, Inc. | Prostate associated Ets protein |
WO2000006589A1 (en) * | 1998-07-31 | 2000-02-10 | Human Genome Sciences, Inc. | Prostate derived ets factor |
WO2000055173A1 (en) * | 1999-03-12 | 2000-09-21 | Human Genome Sciences, Inc. | Human breast and ovarian cancer associated gene sequences and polypeptides |
WO2000070092A1 (en) * | 1999-05-14 | 2000-11-23 | Chiron Corporation | Expression of ets-domain proteins in cancer |
Non-Patent Citations (6)
Title |
---|
DATABASE EBI Hinxton, UK; 14 December 1998 (1998-12-14), OETTGEN ET AL, XP002183898 * |
OETTGEN ET AL: "PDEF, a novel prostate epithelium-specific Ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 275, no. 2, January 2000 (2000-01-01), pages 1216 - 1225, XP002148117 * |
See also references of EP1234037A2 * |
SEMENTCHENKO V I ET AL: "ETS2 FUNCTION IS REQUIRED TO MAINTAIN THE TRANSFORMED STATE OF HUMAN PROSTATE CANCER CELLS", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 17, no. 22, 1998, pages 2883 - 2888, XP000946164, ISSN: 0950-9232 * |
TRAIL P A ET AL: "Monoclonal antibody drug conjugates in the treatment of cancer", CURRENT OPINION IN IMMUNOLOGY, CURRENT BIOLOGY LTD, XX, vol. 11, no. 5, 1 October 1999 (1999-10-01), pages 584 - 588, XP004257589, ISSN: 0952-7915 * |
YAMADA NAOKO ET AL: "Cloning and expression of the mouse Pse gene encoding a novel Ets family member.", GENE (AMSTERDAM), vol. 241, no. 2, 11 January 2000 (2000-01-11), pages 267 - 274, XP001041527, ISSN: 0378-1119 * |
Also Published As
Publication number | Publication date |
---|---|
NO20022542L (en) | 2002-07-29 |
JP2003533177A (en) | 2003-11-11 |
EP1234037A2 (en) | 2002-08-28 |
AU4306401A (en) | 2001-06-18 |
WO2001042472A2 (en) | 2001-06-14 |
HK1049352A1 (en) | 2003-05-09 |
NO20022542D0 (en) | 2002-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001038486A3 (en) | Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies | |
WO2002060932A3 (en) | A serpin in bifidobacteria | |
WO2000039304A3 (en) | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof | |
NZ504548A (en) | Polypeptides and nucleic acids encoding human chordin | |
WO2002059315A3 (en) | Human nucleic acids and polypeptides and methods of use thereof | |
WO2002062999A8 (en) | Proteins and nucleic acids encoding same | |
DE69637856D1 (en) | Interleukin-19. | |
WO2002081517A3 (en) | Novel polypeptides and nucleic acids encoded thereby | |
WO2002046409A3 (en) | Proteins and nucleic acids encoding same | |
WO2003007699A3 (en) | Transcription factors of cereals | |
WO2001044291A3 (en) | Polynucleotid encoding the rg1 polypeptide | |
WO2000069884A3 (en) | Compositions isolated from skin cells and methods for their use | |
WO2000052136A3 (en) | Human glycosylation enzymes | |
WO2000073323A3 (en) | Adam polynucleotides and polypeptides | |
EP1366146A4 (en) | Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof | |
WO2001042472A3 (en) | DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE | |
WO2001081577A3 (en) | Dna encoding the prost 03 polypeptide | |
WO2002085922A3 (en) | Proteins and nucleic acids encoding same | |
WO2000020450A3 (en) | Calcium channel alpha-2/delta gene | |
WO2002090500A3 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
WO1998029438A3 (en) | Cortistatin polypeptides | |
WO2002046408A3 (en) | Human proteins, polynucleotides encoding them and methods of using the same | |
WO2003031586A3 (en) | Acrp30-like polynucleotides, polypeptides, and antibodies | |
WO2002081629A3 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
WO2003091402A3 (en) | N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000992356 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 544345 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 2000992356 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000992356 Country of ref document: EP |